前收市價 | 100.93 |
開市 | 99.07 |
買盤 | 66.00 x 900 |
賣出價 | 125.00 x 800 |
今日波幅 | 97.18 - 100.26 |
52 週波幅 | 45.38 - 103.66 |
成交量 | |
平均成交量 | 504,517 |
市值 | 5.066B |
Beta 值 (5 年,每月) | 1.10 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -2.75 |
業績公佈日 | 2024年5月01日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 106.55 |
Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
Glaukos' (GKOS) shares have risen year to date on the back of strong fundamentals. However, rising costs can be a cause of concern.
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.